Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Watch B&M European Value Retail S.A. (DI) (BME) by Zaven Boyrazian in The Motley Fool
- Buy Melrose Industries (MRO) by Zaven Boyrazian in The Motley Fool
- Avoid WPP (WPP) by Royston Wild in The Motley Fool
- Buy Legal & General Group (LGEN) by Royston Wild in The Motley Fool
- Avoid Barclays (BARC) by Christopher Ruane in The Motley Fool
- Buy easyJet (EZJ) by Tom Winnifrith in ShareProphets
- Buy easyJet (EZJ) by Steve Moore in ShareProphets
- Avoid Tekmar Group (TGP) by Steve Moore in ShareProphets
- Buy Tristel (TSTL) by Mark Rogers in The Motley Fool
- Sell Mind Gym (MIND) by Steve Moore in ShareProphets
- Neutral Rio Tinto (RIO) by UBS
- Buy Baltic Classifieds Group (BCG) by Berenberg
- Underperform Whitbread (WTB) by Bernstein
- Buy Rolls-Royce Holdings (RR.) by Bank of America
- Buy Melrose Industries (MRO) by Bank of America
- Buy BAE Systems (BA.) by Bank of America
- Buy Babcock International Group (BAB) by Bank of America
- Buy Sirius Real Estate Ltd. (SRE) by Deutsche Bank
- Buy Helical (HLCL) by Deutsche Bank
- Buy Balfour Beatty (BBY) by Deutsche Bank
Verici DX (VRCI) Share Price
Health Care Sector
NOTE: This is based on 13 open tips for Verici DX (VRCI)
| Latest Bid : 0.80p | Latest Ask : 0.90p |
| High Today : 0.90p | Low Today : 0.83p |
| This Years High : 5.75p | This Years Low : 0.52p |
| Volume : 1,036,495 | MKT Cap : £2.18M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Verici DX (VRCI) Overview
Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.Verici DX (VRCI) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Steve Moore | Premium Only | 2025-07-21 11:25:00 21/07/2025 | -80.00% |
| Sell | Steve Moore | Premium Only | 2025-06-11 16:25:00 11/06/2025 | 28.00% |
| Avoid | Steve Moore | Premium Only | 2025-04-07 11:10:00 07/04/2025 | 40.00% |
| Avoid | Steve Moore | Premium Only | 2024-10-11 14:50:00 11/10/2024 | 82.00% |
| Avoid | Steve Moore | Premium Only | 2024-02-14 16:05:00 14/02/2024 | 89.41% |
Verici DX (VRCI) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 0.80p | Latest Ask : 0.90p |
| High Today : 0.90p | Low Today : 0.83p |
| This Years High : 5.75p | This Years Low : 0.52p |
| Volume : 1,036,495 | MKT Cap : £2.18M |
Verici DX Overview
Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Verici DX Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Steve Moore | Premium Only | 2025-07-21 11:25:00 21/07/2025 | -80.00% |
| Sell | Steve Moore | Premium Only | 2025-06-11 16:25:00 11/06/2025 | 28.00% |
| Avoid | Steve Moore | Premium Only | 2025-04-07 11:10:00 07/04/2025 | 40.00% |
| Avoid | Steve Moore | Premium Only | 2024-10-11 14:50:00 11/10/2024 | 82.00% |
| Avoid | Steve Moore | Premium Only | 2024-02-14 16:05:00 14/02/2024 | 89.41% |